We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Circassia has slumped at the Phase 2 clinical trial stage again, after its failure with a treatment for those with an allergy to cats. At that point...